{"transactions":[{"id":742102,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T16:56:20.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":16556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 16,556 restricted stock units that vests in full (i) immediately prior to the Company's next annual meeting; or (ii) one year from the date of grant, whichever is earlier."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) the award described in footnote (1) above, (b) 12,525 shares of common stock purchased on March 16, 2026, (c) 8,475 shares of common stock purchased on March 17, 2026, and (d) 11,000 restricted stock units that fully vest on December 17, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1. The 11,000 restricted stock units referenced in Footnote 2(d) were previously reported as covering 110,000 restricted stock units. This number has been adjusted to reflect the stock split that occurred on March 13, 2026."}],"balance_after":48556,"source":{"system":"sec-edgar","filing":"0001171843-26-004060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326004060/ownership.xml","form_type":"4"}},{"id":835499,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T11:31:56.000Z","date":"2026-03-17","kind":"purchase","planned":false,"acquired":true,"shares":8475,"price":4.85,"value":41103.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. These shares were purchased in multiple transactions, and the prices actually paid ranged from $4.80 to $4.95, inclusive. The reporting person has provided to the Issuer, and will provide to any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) 12,525 shares of common stock purchased on March 16, 2026, (b) 8,475 shares of common stock purchased on March 17, 2026, and (c) 11,000 restricted stock units that fully vest on December 17, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1. The 11,000 restricted stock units referenced in Footnotes 3(b) and 4(c) were previously reported as covering 110,000 restricted stock units. These numbers have been adjusted to reflect the stock split that occurred on March 13, 2026."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001171843-26-001689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326001689/ownership.xml","form_type":"4"}},{"id":835498,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-18T11:31:56.000Z","date":"2026-03-16","kind":"purchase","planned":false,"acquired":true,"shares":12525,"price":4.99,"value":62499.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. These shares were purchased in multiple transactions, and the prices actually paid ranged from $4.85 to $5.00, inclusive. The reporting person has provided to the Issuer, and will provide to any security holder of the Issuer, or the Securities and Exchange Commission (\"SEC\") staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) 12,525 shares of common stock purchased on March 16, 2026, and (b) 11,000 restricted stock units that fully vest on December 17, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"On March 13, 2026, the common stock of Harvard Bioscience, Inc. underwent a reverse stock split in a ratio of 10-for-1. The 11,000 restricted stock units referenced in Footnotes 3(b) and 4(c) were previously reported as covering 110,000 restricted stock units. These numbers have been adjusted to reflect the stock split that occurred on March 13, 2026."}],"balance_after":23525,"source":{"system":"sec-edgar","filing":"0001171843-26-001689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326001689/ownership.xml","form_type":"4"}},{"id":957498,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-31T01:48:41.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of 110,000 restricted stock units that fully vest on December 17, 2026."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001171843-25-008127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325008127/ownership.xml","form_type":"4"}},{"id":1864062,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Long-Term Warrant","published_at":"2023-06-07T16:11:03.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":846274,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock was sold in fixed combinations with the warrants, with BroadOak Fund IV, LLC (\"BroadOak\") receiving (a) a Short-Term Warrant (as defined in the Purchase Agreement) to purchase one-half of a share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak and (b) a Long-Term Warrant (as defined in the Purchase Agreement) to purchase one share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak. The purchase price per share of Preferred Stock and accompanying Short-Term Warrant and Long-Term Warrant was $100.00."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"BroakOak may elect to receive to receive a Pre-Funded Warrant (as defined in the Purchase Agreement) in lieu of shares of Common Stock upon exercise of the Short-Term or Long-Term Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Preferred Stock, Short-Term Warrant and Long-Term Warrant held of record by BroadOak. BroadOak Asset Management, LLC is the manager and general partner of BroadOak, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":846274,"derivative":{"exercise_price":2.5996,"exercise_date":"2023-06-05","expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":846274},"source":{"system":"sec-edgar","filing":"0001209191-23-035056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000120919123035056/doc4.xml","form_type":"4"}},{"id":1864061,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Short-Term Warrant","published_at":"2023-06-07T16:11:03.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":423137,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock was sold in fixed combinations with the warrants, with BroadOak Fund IV, LLC (\"BroadOak\") receiving (a) a Short-Term Warrant (as defined in the Purchase Agreement) to purchase one-half of a share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak and (b) a Long-Term Warrant (as defined in the Purchase Agreement) to purchase one share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak. The purchase price per share of Preferred Stock and accompanying Short-Term Warrant and Long-Term Warrant was $100.00."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"BroakOak may elect to receive to receive a Pre-Funded Warrant (as defined in the Purchase Agreement) in lieu of shares of Common Stock upon exercise of the Short-Term or Long-Term Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Preferred Stock, Short-Term Warrant and Long-Term Warrant held of record by BroadOak. BroadOak Asset Management, LLC is the manager and general partner of BroadOak, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":423137,"derivative":{"exercise_price":2.5996,"exercise_date":"2023-06-05","expiration_date":"2025-06-05","underlying":"Common Stock","underlying_shares":423137},"source":{"system":"sec-edgar","filing":"0001209191-23-035056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000120919123035056/doc4.xml","form_type":"4"}},{"id":1864060,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Redeemable Convertible Preferred Stock","published_at":"2023-06-07T16:11:03.000Z","date":"2023-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Preferred Stock was sold in fixed combinations with the warrants, with BroadOak Fund IV, LLC (\"BroadOak\") receiving (a) a Short-Term Warrant (as defined in the Purchase Agreement) to purchase one-half of a share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak and (b) a Long-Term Warrant (as defined in the Purchase Agreement) to purchase one share of Common Stock per each share of Common Stock initially underlying the Preferred Stock purchased by BroadOak. The purchase price per share of Preferred Stock and accompanying Short-Term Warrant and Long-Term Warrant was $100.00."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Redeemable Convertible Preferred Stock, par value $0.0001 per share, (the \"Preferred Stock\") has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Pursuant to the Certificate of Designation contemplated by the Redeemable Convertible Preferred Stock and Warrant Purchase Agreement dated as of May 31, 2023 (the \"Purchase Agreement\") (the \"Certificate of Designation\"), each share of Preferred Stock may be converted at any time into Common Stock as is determined by dividing (i) the sum of the Accrued Value (as defined in the Certificate of Designation) plus an amount equal to all accrued or declared and unpaid dividends on the Preferred Stock that have not previously been added to the Accrued Value by (ii) the Conversion Price in effect at the time of conversion. The \"Conversion Price\" shall initially be equal to $2.3633 per share. The rate at which shares of Preferred Stock may be converted into shares of Common Stock shall be subject to adjustment pursuant to the Certificate of Designation.  Each share of Preferred Stock is initially convertible into approximately 42.3 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Preferred Stock, Short-Term Warrant and Long-Term Warrant held of record by BroadOak. BroadOak Asset Management, LLC is the manager and general partner of BroadOak, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":20000,"derivative":{"exercise_price":2.3633,"exercise_date":"2023-06-05","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001209191-23-035056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000120919123035056/doc4.xml","form_type":"4"}},{"id":2234315,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T18:09:30.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":30945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date.  \"Grant Date\" shall mean June 9, 2022."}],"balance_after":30945,"derivative":{"exercise_price":3.49,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":30945},"source":{"system":"sec-edgar","filing":"0001850079-22-000048","document":"wf-form4_165515815656608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007922000048/wf-form4_165515815656608.xml","form_type":"4"}},{"id":2234314,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T18:09:30.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":20630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Codex DNA, Inc.'s (the \"Issuer\") Common Stock.  Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock  Incentive Plan) through each such date, one hundred percent (100%) of the RSUs shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date.  \"Grant Date\" shall mean June 9, 2022."}],"balance_after":20630,"source":{"system":"sec-edgar","filing":"0001850079-22-000048","document":"wf-form4_165515815656608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007922000048/wf-form4_165515815656608.xml","form_type":"4"}},{"id":2657599,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-06-23T16:06:08.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":277368,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by BroadOak Fund IV, LLC. BroadOak Asset Management, LLC is the manager and general partner of BroadOak Fund IV, LLC, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak Fund IV, LLC, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":277368},"source":{"system":"sec-edgar","filing":"0001850079-21-000032","document":"wf-form4_162447874769144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007921000032/wf-form4_162447874769144.xml","form_type":"4"}},{"id":2657598,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-23T16:06:08.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":541677,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by BroadOak Fund IV, LLC. BroadOak Asset Management, LLC is the manager and general partner of BroadOak Fund IV, LLC, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak Fund IV, LLC, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":541677},"source":{"system":"sec-edgar","filing":"0001850079-21-000032","document":"wf-form4_162447874769144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007921000032/wf-form4_162447874769144.xml","form_type":"4"}},{"id":2657597,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Z Preferred Stock","published_at":"2021-06-23T16:06:08.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by BroadOak Fund IV, LLC. BroadOak Asset Management, LLC is the manager and general partner of BroadOak Fund IV, LLC, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak Fund IV, LLC, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001850079-21-000032","document":"wf-form4_162447874769144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007921000032/wf-form4_162447874769144.xml","form_type":"4"}},{"id":2657596,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":39390,"kind":"person","name":"Snider William","position":1,"cik":"0001340831","reported_name":"Snider William","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T16:06:08.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":1319045,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Z Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.  The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by BroadOak Fund IV, LLC. BroadOak Asset Management, LLC is the manager and general partner of BroadOak Fund IV, LLC, and BroadOak Capital Partners, LLC is the managing member of BroadOak Asset Management, LLC. William F. Snider is a partner and manager of BroadOak Capital Partners, LLC. Each of Mr. Snider and BroadOak Capital Partners, LLC may be deemed to have voting and dispositive power over the shares held by BroadOak Fund IV, LLC, and each disclaims beneficial ownership of such shares except to the extent of his/its indirect pecuniary interest therein, if any."}],"balance_after":2319045,"source":{"system":"sec-edgar","filing":"0001850079-21-000032","document":"wf-form4_162447874769144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850079/000185007921000032/wf-form4_162447874769144.xml","form_type":"4"}}]}